ENSION Inc

Pittsburgh, PA · Medtech · Private

Ension Triad System (ETS), an in vitro blood compatibility testing platform that simultaneously evaluates thrombosis, coagulation, platelets, leukocyte activation, and complement under physiological c

ension.com →
Grants
$7.6M
12 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$9.7M
5 awards · Health and Human S, Defense
#71 of 4531 in medtech
Patents
22
8 granted · 14 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Pediatric Circulatory Support$3,688,807
Federal contractDepartment of Defense · SBIR Phase 1, Topic$99,987
Federal contractDepartment of Health and Human Services · Critical Technologies For Ventricular Assist Devices$118,327
Federal contractDepartment of Health and Human Services · TAS::75 0872::TAS Pumps For Kids, Infants, And Neonates (pumpkin)$5,137,033
Federal contractDepartment of Defense · Tatrc Csi R&d Proposal #10071015$689,211
Federal grantDepartment of Health and Human Services · Phase I · Architecturally Enhanced and Reinforced Regenerative Collagen Matrix for Wound Healing Applications$224,971
Federal grantDepartment of Health and Human Services · Phase I · Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies$356,976
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · System and comprehensive approach for blood compatibility of medical devices and biomaterials$257,843
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · System and comprehensive approach for blood compatibility of medical devices and biomaterials$257,843
Federal grantDepartment of Health and Human Services · Phase I · Development of bioactive surface for pediatric hemodialysis catheters to prevent thrombogenic, inflammatory and biofilm complications$299,832
Federal grantDepartment of Health and Human Services · Phase I · Development of bioactive surface for pediatric hemodialysis catheters to prevent thrombogenic inflammatory and biofilm complications$299,832
Federal grantDepartment of Health and Human Services · Phase II · System and comprehensive approach for blood compatibility of medical devices and biomaterial$1,261,442
Federal grantDepartment of Health and Human Services · Phase II · System and comprehensive approach for blood compatibility of medical devices and biomaterial$1,261,442
Federal grantDepartment of Health and Human Services · Phase II · Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies - Phase II$798,861
Federal grantDepartment of Health and Human Services · Phase II · Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies - Phase II$652,543
Federal grantDepartment of Health and Human Services · Phase II · Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications$870,467
Federal grantDepartment of Health and Human Services · Phase II · Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications$1,025,048
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
68Biomeme Inc$11M$5.5M
69iWalk, Inc.$10M$57M
70THE ULTRAN GROUP, INC.$9.8M—
71ENSION Inc$9.7M—
72SHARP VISION SOFTWARE LLC$9.6M—
73Rapid Micro Biosystems$9.3M$120M
74PLATYPUS TECHNOLOGIES LLC$9.2M$154K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 8 granted of 22

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.